HealthInvest Partners AB »

Compass Therapeutics shares owned by HealthInvest Partners AB

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by HealthInvest Partners AB from 13F filings

Historical chart of HealthInvest Partners AB investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by HealthInvest Partners AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by HealthInvest Partners AB

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.1M 584k 5.37

More positions owned by HealthInvest Partners AB

Eli Lilly & Co. (LLY)
Abbvie (ABBV)
Merck & Co (MRK)
Thermo Fisher Scientific (TMO)
Neurocrine Biosciences (NBIX)
Intuitive Surgical Com New (ISRG)
Beone Medicines Ltd- Sponsored Ads (ONC)
Bridgebio Pharma (BBIO)
Vertex Pharmaceuticals Incorporated (VRTX)
Boston Scientific Corporation (BSX)
Stryker Corporation (SYK)
CVS Caremark Corporation (CVS)
Krystal Biotech (KRYS)
AmerisourceBergen (COR)
Ionis Pharmaceuticals (IONS)

View all positions for HealthInvest Partners AB

Top funds holding Compass Therapeutics

Tang Capital Management
OrbiMed Advisors
Suvretta Capital Management
Blackstone Group
Vivo Capital
BlackRock
Vanguard Group
Enavate Sciences GP
Adage Capital Partners GP
State Street Corporation
BVF
FMR
Rock Springs Capital Management
Deerfield Management Company
Geode Capital Management

View all funds holding Compass Therapeutics